Search results for "ADH"

showing 10 items of 2081 documents

Case Management for Depression by Health Care Assistants in Small Primary Care Practices

2009

BACKGROUND: Case management by health care assistants in small primary care practices provides unclear benefit for improving depression symptoms. OBJECTIVE: To determine whether case management provided by health care assistants in small primary care practices is more effective than usual care in improving depression symptoms and process of care for patients with major depression. DESIGN: Cluster randomized, controlled trial. A central automated system generated the randomization scheme, which was stratified by urban and rural practices; allocation sequence was concealed until groups were assigned. SETTING: 74 small primary care practices in Germany from April 2005 to September 2007. PATIEN…

11035 Institute of General PracticeAdultMalemedicine.medical_specialtyAdolescentQuality Assurance Health CareAllied Health Personnel610 Medicine & healthMedication Adherencelaw.inventionInterviews as TopicYoung AdultQuality of life (healthcare)Ambulatory careRandomized controlled triallawGermanySurveys and QuestionnairesHealth careInternal MedicinemedicineHumansProspective StudiesCluster randomised controlled trialPsychiatryDepression (differential diagnoses)AgedAged 80 and overDepressive Disorderbusiness.industryPublic healthGeneral MedicineMiddle AgedAntidepressive AgentsTelephoneOutcome and Process Assessment Health Care2724 Internal MedicineFamily medicineManaged careFemaleFamily PracticebusinessCase ManagementAnnals of Internal Medicine
researchProduct

Emotions and Opinions of Adult Patients with Haemophilia During the COVID-19 (Coronavirus Disease 2019) Pandemic Caused by SARS-CoV-2: A Monocentric …

2020

Mariasanta Napolitano, 1 Maria Francesca Mansueto, 1 Davide Sirocchi, 1 Angelo Davide Contrino, 1 Simona Raso, 2 Sergio Siragusa 1 1Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Haematology Unit, Reference Regional Centre for Thrombosis and Haemostasis, University of Palermo, Palermo, Italy; 2Division of Haematology, Department of Surgical, Oncological and Stomatological Disciplines (Di.Chir.On.S.), AOUP Paolo Giaccone, Palermo, ItalyCorrespondence: Mariasanta NapolitanoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), Haematology Unit, Reference Regional Centre for Thromb…

2019-20 coronavirus outbreakHaemophiliaAdult patientsCoronavirus disease 2019 (COVID-19)business.industryHealth PolicySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Medicine (miscellaneous)Haemophiliamedicine.diseaseVirologyPatient Preference and AdherencePandemicSARS-Cov2 emotionsResearch LettermedicinebusinessPharmacology Toxicology and Pharmaceutics (miscellaneous)Social Sciences (miscellaneous)Patient Preference and Adherence
researchProduct

Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment

2019

Chronic obstructive pulmonary disease (COPD) is one of the main health problems worldwide. It is characterised by chronic inflammation in the lungs that leads to progressive, chronic, largely irreversible airflow obstruction. The use of long-acting β agonists remain today the frontline treatment for COPD with the aim of minimizing side effects and enhancing therapeutic usefulness. To this purpose, in this paper, mucoadhesive solid lipid microparticles (SLMs) containing a long-acting β-2 agonist, Salmeterol Xinafoate (SX) were prepared, characterised (size, z-potential, aerodynamic diameter, turbidimetric evaluations, drug loading and entrapping efficiency) and tested in a model of bronchial…

3003AgonistDrugAlginatesCell Survivalmedicine.drug_classmedia_common.quotation_subjectSodium alginate polymerPharmaceutical ScienceChronic obstructive pulmonary disease (COPD)Inflammation02 engineering and technologyPharmacology030226 pharmacology & pharmacyCell LinePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinecAMPmedicineHumansAerodynamic diameterAdrenergic beta-2 Receptor AgonistsSalmeterol Xinafoatemedia_commonDrug CarriersCOPDInhalationChemistryTherapeutic effectAdhesiveness021001 nanoscience & nanotechnologymedicine.diseaseLipidsSALMETEROL XINAFOATEBronchodilator Agentsrespiratory tract diseasesSalmeterol Xinafoate (SX)MucusAerodynamic diametermedicine.symptom0210 nano-technologyInternational Journal of Pharmaceutics
researchProduct

Spray dried hyaluronic acid microparticles for adhesion controlled aggregation and potential stimulation of stem cells

2017

Spray-dried microparticles of a derivative of hyaluronic acid (HA) have been engineered to obtain a controlled aggregation with Human Mesenchymal Stem Cells (hMSCs) into 3D constructs. We demonstrated the utility of chemical functionalization of a native constituent of the extracellular matrix to improve processing performances and to control on stem cell adhesion and differentiation. Native hyaluronic acid (HA), cell adhesive peptides (RGD), transforming growth factor β3, dexamethasone are biological agents potentially suitable for chondrogenic stimulation of hMSCS. However unmodified HA suffers of drawbacks in terms of stability and versatility of processing. Functionalization strategies…

3003Hyaluronic acid0206 medical engineeringPharmaceutical Science02 engineering and technologyDexamethasoneExtracellular matrixchemistry.chemical_compoundTissue engineeringTransforming Growth Factor betaHyaluronic acidCell AdhesionHumansCell adhesionCells CulturedBottom-up approachStem cellMesenchymal Stromal CellTissue EngineeringChemistryMesenchymal stem cellMesenchymal Stem CellsCell DifferentiationAdhesion021001 nanoscience & nanotechnology020601 biomedical engineeringExtracellular MatrixBiochemistryMicroparticleSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoSurface modificationChondrogenesiStem cell0210 nano-technologyChondrogenesisHuman
researchProduct

Hyaluronic acid and alpha-elastin based hydrogel for three dimensional culture of vascular endothelial cells

2018

Abstract The aim of this work was to demonstrate that employing a copolymer of hyaluronic acid and α-elastin (HA-EDA-g-α-elastin) is possible to produce a scaffold able to support the adhesion and growth of human vascular endothelial cells (HUVEC) thanks to its ability to incorporate and control the diffusion of vascular endothelial growth factor (VEGF). HA-EDA-g-α-elastin was crosslinked with low molecular weight hyaluronic acid (HALMW) to obtain a hydrogel that gives rise to the formation of three dimensional sponge after the freeze drying process. The physicochemical features the obtained material along with its ability to act as a support for the three dimensional culture of endothelial…

3003Scaffoldmedicine.medical_treatmentHyaluronic acidPharmaceutical ScienceWound healing02 engineering and technologymacromolecular substances010402 general chemistry01 natural scienceschemistry.chemical_compoundFreeze-dryingHyaluronic acidmedicinebiologyGrowth factorAdhesion021001 nanoscience & nanotechnology0104 chemical sciencesElastinVascular endothelial growth factorHydrogelchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsbiology.proteinVascular endothelial growth factor0210 nano-technologyWound healingElastin
researchProduct

Enhanced adhesion and in situ photothermal ablation of cancer cells in surface-functionalized electrospun microfiber scaffold with graphene oxide

2017

The physicochemical characteristics of a biomaterial surface highly affect the interaction with living cells. Recently, much attention has been focused on the adhesion properties of functional biomaterials toward cancer cells, since is expected to control metastatic spread of a tumor, which is related to good probability containing the progression of disease burden. Here, we designed an implantable poly(caprolactone)-based electrospun microfiber scaffold, henceforth PCLMF-GO, to simultaneously capture and kill cancer cells by tuning physicochemical features of the hybrid surface through nitrogen plasma activation and hetero-phase graphene oxide (GO) covalent functionalization. The surface i…

3003business.product_categoryCancer therapyPharmaceutical ScienceNanotechnologyBiocompatible Materials02 engineering and technologyCell capture010402 general chemistry01 natural scienceslaw.inventionPlasmalawNeoplasmsMicrofiberCell AdhesionHumansCell adhesionGraphene oxideHybrid materialChemistryGrapheneBiomaterialOxidesAdhesionPhotothermal therapyPhototherapy021001 nanoscience & nanotechnology0104 chemical sciencesPolycaprolactoneCancer cellMCF-7 CellsSurface modificationGraphite0210 nano-technologybusiness
researchProduct

PLLA scaffolds with controlled architecture as potential microenvironment for in vitro tumor model

2019

Abstract The "microenvironment" where a tumor develops plays a fundamental role in determining its progression, the onset of metastasis and, eventually, its resistance to therapies. Tumor cells can be considered more or less invasive depending both on the nature of the cells and on the site where they are located. Commonly adopted laboratory culture protocols for the investigation of tumor cells take usually place on standard two-dimensional supports. However, such cultures do not allow for reproduction of the biophysical properties of the tumor’s microenvironment, thus causing the cells to lose most of their relevant characteristics. In this work MDA-MB 231 breast cancer cells were cultiva…

3D tumor modelPolyestersCellBreast Neoplasms02 engineering and technologyBiologyModels BiologicalMetastasis03 medical and health scienceschemistry.chemical_compoundCell Line TumorTumor MicroenvironmentmedicineHumansViability assayDAPICell adhesion030304 developmental biologySettore ING-IND/24 - Principi Di Ingegneria Chimica0303 health sciencesTissue ScaffoldsSettore ING-IND/34 - Bioingegneria IndustrialeBreast cancer cellCell BiologyGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseIn vitroLactic acidStainingmedicine.anatomical_structurechemistryBiophysicsFemaleThermally induced phase separation0210 nano-technologyPoly-L-Lactic acidDevelopmental BiologyTissue and Cell
researchProduct

1985. La adhesión de España a la Comunidad Económica Europea.

2014

La adhesión de España a la Comunidad Económica Europea. El 12 de junio de 1985 España y Portugal se adhirieron a la Comunidad Económica Europea, CEE. El Acta de Adhesión de España a las Comunidades Europeas se firmó en Madrid, en el acto protocolario que tuvo lugar en el Salón de Columnas del Palacio Real, en presencia del rey de España, Juan Carlos I. Firmaron el Acta de Adhesión el presidente del Gobierno Felipe González Márquez, el ministro de Asuntos Exteriores Fernando Morán López y Manuel Marín González, secretario de Estado de Relaciones con las Comunidades Europeas. La entrada de España en la CEE suponía el fin del aislacionismo de España, abriendo lo que iba a ser la época de mayor…

:CIENCIA POLÍTICA [UNESCO]Adhesión de España a la Comunidad Económica EuropeaUNESCO::HISTORIAUNESCO::CIENCIA POLÍTICAUNESCO::SOCIOLOGÍA:SOCIOLOGÍA [UNESCO]:HISTORIA [UNESCO]Comunidad ValencianaOTANMercado ComúnCEE
researchProduct

Estudio de la quiescencia y activación de las células madre neurales adultas por uniones adherentes: papel de la N-cadherina.

2017

El descubrimiento de poblaciones de células madre en el cerebro adulto (NSCs) de los mamíferos ha cambiado nuestra visión del sistema nervioso, añadiendo el concepto de plasticidad celular al de plasticidad neural. El conocimiento detallado de los mecanismos que permiten a las NSCs mantenerse indiferenciadas, dividirse de manera asimétrica para auto-perpetuarse mientras generan progenie diferenciada, y activarse para proliferar contribuyendo así a la renovación de ciertas poblaciones de neuronas durante toda la vida se ha convertido en un campo de investigación en continuo avance. El desarrollo de técnicas que permiten la posibilidad de expandir las NSCs in vitro y de estudiarlas en su micr…

:CIENCIAS DE LA VIDA::Biología celular [UNESCO]zona subependimarianeurogénesiscélulas madre neurales adultasUNESCO::CIENCIAS DE LA VIDA::Neurociencias:CIENCIAS DE LA VIDA::Neurociencias [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Biología celularn-cadherinaproliferación
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct